Ron DeSantis’ Fundraiser Is Being Paid For By The Elites

According to a report, The DeSantis campaign continues with a stop at an elite, high-profile fundraiser party thrown by Marc Lampkin in the nation’s capital. Members of the host committee are expected to generate at least fifty thousand dollars to support the Ron DeSantis’ campaign. 

Lampkin is a prominent lobbyist with Brownstein Hyatt Farber Schreck and an outspoken Bush supporter. Lampkin is an advocate of drug companies and child puberty inhibitors. The Brownstein Hyatt Farber Schreck Hyatt headquarters will host the charity event.

The website for the legal firm Farber Schreck boasts a proven commitment to recruiting attorneys of color, LGBTQ+, female lawyers, and those with disabilities, among other examples of the firm’s commitment to diversity and inclusion.

Lampkin lobbied on behalf of Abbvie INC, a manufacturer of puberty inhibitors for children, while at Schreck. In addition, Lampkin lobbied for Moderna.

A report suggests that this creates a precarious situation for Florida’s governor, who is hoping to ride anti-vaxxer anger and his record of banning gender-affirming therapy to the White House.

Marc Lampkin disagrees with DeSantis and the Republican Party on many hot-button topics. 

DeSantis has prohibited transgender therapy for kids in Florida and is actively pursuing a grand jury inquiry into Moderna. 

The Trump team wasted no time attacking DeSantis, saying the governor was beholden to his “globalist masters” and thus hypocritical.

The upcoming event hosted by Schreck, the largest federal lobbying firm in Washington, DC, has been met with criticism. According to a June 23 invitation acquired by DailyMail.com, supporters of DeSantis may purchase a spot for a $1,000 contribution.

Documents filed under the Foreign Agents Registration Act (FARA) reveal that he worked with the Chinese state-owned semiconductor manufacturer Fujian Jinhua. 

The Trump administration declared it a national security concern and instituted sanctions against it in 2018.